ホーム>>Peptides>>Biotin Tripeptide-1

Biotin Tripeptide-1 (Synonyms: Biotinoyl Tripeptide-1, Biotinyl-GHK, Biotinyl-Gly-His-Lys)

カタログ番号GC42936

ビオチントリペプチド-1は、バイオチンに結合された細胞外マトリックス(ECM)ペプチドです。

Products are for research use only. Not for human use. We do not sell to patients.

Biotin Tripeptide-1 化学構造

Cas No.: 299157-54-3

サイズ 価格 在庫数 個数
25mg
$43.00
在庫あり
50mg
$82.00
在庫あり
100mg
$155.00
在庫あり
250mg
$365.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Background

ビオチントリペプチド-1は、バイオチンに結合された細胞外マトリックス(ECM)ペプチドであり、皮膚および表皮細胞のコラーゲンIVおよびラミニンの産生を刺激します。ビオチントリペプチド-1は、単離培養された人間毛包の周囲毛包帯に局在し、角化細胞の増殖を誘導し、2 ppmおよび5 ppmの濃度で使用した場合に対照毛包と比較して58%および121%の髪の成長を促進します。また、単離培養された毛包内でコラーゲンIVおよびラミニン5バンドが減少することを防止します。

Chemical Properties

Cas No. 299157-54-3 SDF
同義語 Biotinoyl Tripeptide-1, Biotinyl-GHK, Biotinyl-Gly-His-Lys
Canonical SMILES O=C(NCC(N[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)CC1=CN=CN1)=O)CCCC[C@@H]2[C@@](NC(N3)=O)([H])[C@@]3([H])CS2
Formula C24H38N8O6S M.Wt 566.7
溶解度 DMSO: 5mg/mL,PBS (pH 7.2): 10mg/mL Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.7646 mL 8.823 mL 17.646 mL
5 mM 0.3529 mL 1.7646 mL 3.5292 mL
10 mM 0.1765 mL 0.8823 mL 1.7646 mL
  • モルアリティ計算機

  • 希釈計算機

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

レビュー

Review for Biotin Tripeptide-1

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Biotin Tripeptide-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.